Concepedia

Anil K. Tyagi

AK

Statistics

Publications

70

Citations

3.8K

H-Index

36

Active since

1977

Affiliations

University of Delhi(Current)

National Institute of Research in Tuberculosis

University of Colorado Health

Guru Gobind Singh Indraprastha University

National JALMA Institute for Leprosy & Other Mycobacterial Diseases

Anil K. Tyagi is an author at University of Delhi specializing in life sciences, mycobacterium tuberculosis infection, and immunology.

Publications per year

1977–2019

70

Publications

70

Silibinin strongly synergizes human prostate carcinoma DU145 cells to doxorubicin-induced growth Inhibition, G2-M arrest, and apoptosis.

Anil K. Tyagi, Rana P. Singh, Chapla Agarwal et al. · PubMed · 2002 · 328 citations

Medicine, Oncology, Pharmacology +13

IgG particle formation during filling pump operation: A case study of heterogeneous nucleation on stainless steel nanoparticles

Anil K. Tyagi, Theodore W. Randolph, Aichun Dong et al. · Journal of Pharmaceutical Sciences · 2008 · 192 citations

Natural Sciences, Materials Engineering, Materials Science +17

Dietary feeding of silibinin inhibits advance human prostate carcinoma growth in athymic nude mice and increases plasma insulin-like growth factor-binding protein-3 levels.

Rana P. Singh, Sivanandhan Dhanalakshmi, Anil K. Tyagi et al. · PubMed · 2002 · 192 citations

Medicine, Oncology, Pharmacology +13

Silymarin inhibits growth and causes regression of established skin tumors in SENCAR mice via modulation of mitogen-activated protein kinases and induction of apoptosis

Rana P. Singh, Anil K. Tyagi, Jifu Zhao et al. · Carcinogenesis · 2002 · 148 citations · Full text

Medicine, Oncology, Pharmacology +15

Synergistic Anti-Cancer Effects of Grape Seed Extract and Conventional Cytotoxic Agent Doxorubicin Against Human Breast Carcinoma Cells

Girish Sharma, Anil K. Tyagi, Rana P. Singh et al. · Breast Cancer Research and Treatment · 2004 · 145 citations

Medicine, Oncology, Pharmacology +14

1–5 of 70